A revolutionary RNA - editing tool promises to transform our understanding of RNA's role in our growth and development, and provide a new avenue
for treating infectious diseases and cancer.
While antibiotics have been highly effective
at treating infectious diseases, infectious bacteria have adapted to them and antibiotics have become less effective, according to the Centers for disease Control and Prevention.
«Although our goal is to develop systems that can
treat infectious diseases such as malaria, HIV or tuberculosis in sub-Saharan Africa or Southeast Asia, there are many applications here in the U.S. for treating chronic conditions such as heart disease, diabetes or psychiatric illness.
The takeaway from these experiments is that any number of penicillin - type drugs combined with BPEI or related polymers could create a new first - line drug
for treating infectious diseases and change how MRSA and other infectious bacteria are treated.
«The rise of «superbugs» leaves the clinical community with a rapidly dwindling number of options to
treat infectious disease and to prevent the spread of resistant bacteria in, for example, hospital settings,» explains Professor Vincent O'Flaherty of the National University of Ireland Galway, co-corresponding author on the study, recently published in Frontiers in Microbiology.
► In a Wednesday ScienceInsider, Dennis Normile reported that The Global Health Innovative Technology Fund (GHIT), a Japanese foundation, «will invest up to $ 1 million per candidate «for early stage development of radically new and improved drugs, vaccines or diagnostics to prevent and
treat infectious diseases that are prevalent in developing countries.»»
Livestock producers contend that the spread of resistant strains of bacteria stems from the overuse of all medicines to
treat infectious diseases in both humans and animals.
By countering the microbes» tactics, scientists might be able to design new ways of preventing and
treating infectious disease.
The Global Health Innovative Technology Fund (GHIT) has announced it will invest up to $ 1 million per candidate «for early stage development of radically new and improved drugs, vaccines or diagnostics to prevent and
treat infectious diseases that are prevalent in developing countries.»
While the 3D injectable scaffold is being tested in mice as a potential cancer vaccine, any combination of different antigens and drugs could be loaded into the scaffold, meaning it could also be used to
treat infectious diseases that may be resistant to conventional treatments.
CRISPR gene editing can now target RNA as well as DNA, which could be a way to
treat infectious diseases and cancer and track RNA as it moves around cells
There are a number of drugs used to
treat infectious diseases, with varying levels of success.
Clinical Trials Center This center has focused capabilities to test new candidate drugs and vaccines to prevent and
treat infectious diseases.
Findings from this research are vital to NIAID efforts to create vaccines, drugs, and diagnostic tools to better diagnose, prevent, and
treat infectious diseases.
An associate professor named Janelle Ayres, one of our rising stars, is upending the way
we treat infectious diseases by finding ways to harness the immune system, thereby lessening our dependence on increasingly ineffective antibiotics.
Treatment focuses on preventing complications by monitoring diet,
treating infectious diseases, and managing seizures.
Laboratory and clinical studies on ayurvedic herbal preparations and other therapies have shown them to have a range of potentially beneficial effects for preventing and treating certain cancers,
treating infectious disease, promoting health, and treating aging.
I have seen and
treated infectious diseases in a clinical setting since 1972.
Because of the link between antibiotic use in food - producing animals and the occurrence of antibiotic - resistant infections in humans, antibiotics should be used in food - producing animals only under veterinary oversight and only to manage and
treat infectious diseases, not to promote growth.
Medicines for
treating infectious diseases are not widely available in under - developed countries, and therefore, local hospitals do not have the resources to provide treatment for every infected person.